Form 10 Explorer
10-Q
Quarterly Report
Deep Medicine Acquisition Corp.

DMAQR

NASDAQ

CIK: 1857086

File #: 001-40970

Period End: Sep 30, 2023

Fiscal Year: 2024

View on EDGAR
Balance Sheet
28 line items · 2 periods
XBRL
ItemSep 30, 2023Mar 31, 2023
Assets
Current assets
Cash and Cash Equivalents
357,478595,536
Other Non-Operating Current Assets
20,408
Marketable securities held in Trust Account
6,647,7959,160,803
Fair Value, Inputs, Level 1
6,647,7959,160,803
Total current assets
7,005,2739,776,747
Total assets
7,005,2739,776,747
Liabilities and Stockholders’ (Deficit)
Current liabilities
Related Party
16,0006,000
Nonrelated Party
1,246,550866,500
Taxes Payable
57,56957,569
Related Party
2,065,0001,865,000
Nonrelated Party
84,617
Total current liabilities
3,469,7362,795,069
Non-current liabilities
Retirement Related Liabilities, Non-Current
4,427,5004,427,500
Total non-current liabilities
4,427,5004,427,500
Total liabilities
7,897,2367,222,569
Temporary Equity
6,481,4268,994,434
Stockholders’ (Deficit)
Common Class A
378378
Total Stockholders' Equity
(7,373,767)(6,440,634)
Total Stockholders’ (Deficit)
(7,373,389)(6,440,256)
Common Class A - Common Stock
378378
Retained Earnings
(7,373,767)(6,440,634)
Total Liabilities and Stockholders’ (Deficit)
7,005,2739,776,747
Deep Medicine Acquisition Corp. (DMAQR) — 10-Q Filing | Form 10 Explorer